Evotec (NASDAQ:EVO) Sees Unusually-High Trading Volume

Evotec SE (NASDAQ:EVO) shares saw unusually-strong trading volume on Thursday . Approximately 369,542 shares changed hands during mid-day trading, an increase of 296% from the previous session’s volume of 93,303 shares.The stock last traded at $5.02 and had previously closed at $5.23.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on EVO shares. HC Wainwright lowered their price objective on shares of Evotec from $14.00 to $11.00 and set a “buy” rating on the stock in a research note on Thursday. Deutsche Bank Aktiengesellschaft upgraded shares of Evotec from a “hold” rating to a “buy” rating in a research note on Friday, April 12th. Finally, Royal Bank of Canada upgraded shares of Evotec from a “sector perform” rating to an “outperform” rating in a research note on Thursday, January 18th.

Evotec Price Performance

The firm has a 50-day moving average of $7.29 and a 200 day moving average of $8.65.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. Quadrant Capital Group LLC bought a new position in Evotec in the fourth quarter worth $25,000. Optiver Holding B.V. lifted its position in Evotec by 643.1% in the fourth quarter. Optiver Holding B.V. now owns 80,810 shares of the company’s stock worth $945,000 after purchasing an additional 69,936 shares during the period. Finally, Mubadala Investment Co PJSC bought a new position in Evotec in the fourth quarter worth $53,931,000. 5.81% of the stock is owned by institutional investors.

Evotec Company Profile

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health.